100% Secure Payments
Tender Details
- Country: Czech Republic
- Summary: Rivaroxaban - Anticoagulans, Direct Factor Inhibitor Xa -ii.
- CZT Ref No: 85628266
- Deadline: 25 Jul 2023
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: Public
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: VZ0168936
- Purchaser's Detail :
- Description :
- The subject of the public contract is continuous and repeated supplies of the medicinal product - Rivaroxaban - Anticoagulans, a direct inhibitor of the XA factor ”in the 1st part of the Public Procurement- Rivaroxaban 2.5 mg TBL. FLM.196 TBL RIVAROXABAN 10 mg tbl. FLM. 10 tbl. Rivaroxaban 10 mg tbl. FLM. 30 tbl. Rivaroxaban 15 MQ tbl. FLM. 28 tbl. Rivaroxaban 15 mg tbl. FLM. 42 tbl. Rivaroxaban 15 MQ tbl. FLM. 98 tbl. Rivaroxaban 20 mg tbl. FLM.28 tbl. Rivaroxaban 20 mg tbl. FLM. 98 tbl. Rivaroxaban 1 mg/ml por GRA SUS 1x 2,625 g RIVAROXABAN 1mg/ml POR GRA SUS 1x 5,25 g in 2nd part of the public contract- Rivaroxaban 10 mg tbl. FLM.100 tbl. Rivaroxaban 15 mg tbl. FLM 100 tbl. Rivaroxaban 20 MQ tbl. FLM 100 tbl., In accordance with this ZD and its attachments. Individual deliveries will be realized on the basis of partial orders of the contracting authority-breeds of the University Hospital Ostrava.
- Documents :
Purchaser : UNIVERSITY HOSPITAL OSTRAVA
November 17, 1790/5, 708 52 Ostrava - Poruba, Czech Republic
Phone: +420 597 371 1111
Email :fno@fno.cz
URL :www.fno.cz
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
